Pluvicto for Metastatic Castrate Resistant Prostate Cancer
Robert Zlotecki M.D., PhD describes the factors that make a patient a candidate for Pluvicto treatment for prostate cancer. He explains the process of treatment through a series of Pluvicto infusions for prostate cancer and he outlines the current shift in thinking regarding systemic radiopharmaceutical therapy for prostate cancer.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.